Published in Am J Clin Pathol on May 01, 2008
Biomarkers for colorectal cancer. Int J Mol Sci (2010) 1.19
Direct modification of the proinflammatory cytokine macrophage migration inhibitory factor by dietary isothiocyanates. J Biol Chem (2009) 1.08
Identification of potential therapeutic targets in human head & neck squamous cell carcinoma. Head Neck Oncol (2009) 1.01
D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine (2012) 1.01
Circulating tumor cells in melanoma patients. PLoS One (2012) 0.98
Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals. J Transl Med (2013) 0.94
A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum. Int J Mol Sci (2012) 0.92
PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics. PLoS One (2012) 0.91
Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MS. Mol Cell Proteomics (2009) 0.87
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Br J Cancer (2009) 0.86
Macrophage migration inhibitory factor expression in cervical cancer. J Cancer Res Clin Oncol (2009) 0.84
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma. Int J Med Sci (2013) 0.83
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma. Oncol Lett (2014) 0.82
The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron (2011) 0.81
Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers. PLoS One (2014) 0.80
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies. J Cancer Res Clin Oncol (2013) 0.80
P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor. World J Gastroenterol (2013) 0.76
Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases. Am J Cancer Res (2016) 0.75
MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res (2008) 5.54
The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res (2012) 3.80
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib. J Clin Oncol (2007) 3.70
Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol (2006) 2.62
Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol (2010) 2.35
Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol (2009) 2.32
The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res (2002) 2.24
A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate. Diagn Microbiol Infect Dis (2002) 2.14
The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol (2012) 2.14
Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg (2008) 2.09
Multicenter analysis of risk factors for anastomotic leakage after laparoscopic rectal cancer excision: the Korean laparoscopic colorectal surgery study group. Ann Surg (2013) 2.08
Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer (2007) 1.85
Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res (2011) 1.83
Risk factors for anastomotic leakage after laparoscopic intracorporeal colorectal anastomosis with a double stapling technique. J Am Coll Surg (2009) 1.83
VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth. Mol Ther (2007) 1.75
Totally robotic surgery for rectal cancer: from splenic flexure to pelvic floor in one setup. Surg Endosc (2009) 1.73
Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc (2007) 1.68
A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol (2012) 1.67
Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease. Hum Mutat (2012) 1.65
Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol (2012) 1.56
Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci Signal (2012) 1.56
DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer (2010) 1.55
Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys (2010) 1.52
Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer (2007) 1.49
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics (2006) 1.44
Colorectal flat neoplasia. Dig Liver Dis (2003) 1.43
Colonic ischemia following surgery for sigmoid colon and rectal cancer: a study of 10 cases and a review of the literature. Int J Colorectal Dis (2011) 1.42
Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun (2004) 1.41
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst (2006) 1.40
Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Ann Surg Oncol (2007) 1.36
Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol (2008) 1.32
Solid pseudopapillary tumor of the pancreas suggesting malignant potential. Pancreas (2006) 1.31
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers. Int J Cancer (2007) 1.28
Intestinal endometriosis mimicking carcinoma of rectum and sigmoid colon: a report of five cases. Yonsei Med J (2009) 1.27
New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification. J Clin Microbiol (2010) 1.25
Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases. Clin Biochem (2011) 1.25
Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res (2009) 1.24
Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol (2008) 1.22
Oncologic outcomes of self-expanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg (2009) 1.21
The impact of robotic surgery for mid and low rectal cancer: a case-matched analysis of a 3-arm comparison--open, laparoscopic, and robotic surgery. Ann Surg (2013) 1.19
Clinical outcomes and factors related to resectability and curability of EMR for early colorectal cancer. Gastrointest Endosc (2011) 1.19
Long-term oncologic outcomes of robotic low anterior resection for rectal cancer: a comparative study with laparoscopic surgery. Ann Surg (2015) 1.18
White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans. Am J Epidemiol (2005) 1.18
Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep (2008) 1.18
MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res (2011) 1.16
Bcl-B expression in human epithelial and nonepithelial malignancies. Clin Cancer Res (2008) 1.16
The association between adiponectin and diabetes in the Korean population. Metabolism (2008) 1.16
Long-term outcome of palliative therapy for malignant colorectal obstruction in patients with unresectable metastatic colorectal cancers: endoscopic stenting versus surgery. Gastrointest Endosc (2011) 1.16
Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc (2009) 1.15
Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol (2011) 1.14
Single-site versus conventional laparoscopic appendectomy: comparison of short-term operative outcomes. Surg Endosc (2010) 1.13
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model. Clin Cancer Res (2006) 1.12
Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. Cancer Res (2003) 1.12
Laparoscopic-assisted versus open complete mesocolic excision and central vascular ligation for right-sided colon cancer. Ann Surg Oncol (2014) 1.12
Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res (2005) 1.11
Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. J Cancer Res Clin Oncol (2009) 1.11
Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res (2005) 1.10
FX: an RNA-Seq analysis tool on the cloud. Bioinformatics (2012) 1.10
Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings. Dig Dis Sci (2010) 1.10
Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer (2002) 1.09
Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia (2002) 1.07
Lymphovascular invasion is an important predictor of lymph node metastasis in endoscopically resected early gastric cancers. Oncol Rep (2011) 1.07
Correlation of KIT and platelet-derived growth factor receptor alpha mutations with gene activation and expression profiles in gastrointestinal stromal tumors. Oncogene (2005) 1.06
Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer. Surg Endosc (2013) 1.06
Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer. J Surg Oncol (2012) 1.06
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer. Int J Cancer (2011) 1.05
Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA. J Clin Microbiol (2012) 1.05
Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis. J Hepatol (2009) 1.05
High microsatellite instability predicts good prognosis in intestinal-type gastric cancers. J Gastroenterol Hepatol (2011) 1.04
Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map. Proteomics (2005) 1.04
Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors. PLoS Biol (2007) 1.04
Colonic pseudoobstruction: CT findings. AJR Am J Roentgenol (2008) 1.04
Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clin Vaccine Immunol (2011) 1.03